Emerald Green Trust (Director) Reports Sept 2025 Sales of XOS Shares
Rhea-AI Filing Summary
The filing shows Emerald Green Trust, identified as a director of Xos, Inc. (XOS), reported a series of open-market sales executed under a Rule 10b5-1 trading plan adopted May 27, 2025. Sales occurred on Sept 9–11, 2025, totaling 24,788 shares sold in three transactions at weighted average prices of $2.2762, $2.3463, and $2.3876, respectively. After these transactions the trust reported beneficial ownership of 1,582,134 shares direct. The report is signed by Sarah Bardo, Trustee. The filer discloses price ranges for each sale date and offers to provide per-price details upon request.
Positive
- Transactions executed under a Rule 10b5-1 plan, demonstrating pre-established compliance procedures
- Full disclosure of weighted-average prices and price ranges with offer to provide per-price details upon request
- Filer remains a substantial direct holder with 1,582,134 shares after sales
Negative
- Director sold 24,788 shares, reducing beneficial ownership
- Sales occurred at low single-digit dollar prices, which could reflect prevailing market levels for XOS
Insights
TL;DR Insider sales were executed under a pre-existing 10b5-1 plan, reducing direct holdings while remaining substantially large.
The reported transactions are routine open-market dispositions under a documented Rule 10b5-1 plan adopted May 27, 2025. The trust sold 24,788 shares over three days at modest prices between $2.25 and $2.45, reporting a remaining direct stake of 1,582,134 shares. From a securities-compliance perspective, disclosure is complete: dates, aggregated share counts, weighted-average prices and price ranges are provided and the form is signed by the trustee. These sales do not, by themselves, provide information on company performance and are consistent with scheduled plan-based liquidity.
TL;DR The filing documents compliant, pre-authorized insider sales with clear trustee signature and disclosure of price ranges.
The Form 4 indicates the reporting person is a director filing individually and that transactions were made pursuant to a 10b5-1 trading plan. The inclusion of weighted average prices, price ranges, and an explicit offer to furnish per-price details aligns with best-practice transparency. The trust remains a significant direct holder after the dispositions. No amendments or additional derivative activity are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 11,768 | $2.3876 | $28K |
| Sale | Common Stock | 6,195 | $2.3463 | $15K |
| Sale | Common Stock | 6,825 | $2.2762 | $16K |
Footnotes (1)
- The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025. Represents weighted average sales price. The shares were sold at prices ranging from $2.25 to $2.34. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $2.315 to $2.39. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $2.325 to $2.45. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
